Passive Ring Biomarkers for Women's Health

Diving deeper into

Ultrahuman

Company Report
This model parallels Natural Cycles and Maven Clinic but relies on passive ring biomarkers rather than manual logging.
Analyzed 11 sources

The real shift is that Ultrahuman is turning a smart ring into the front door for women’s health programs that usually start with an app, a questionnaire, or a care navigator. viO adds ovulation confirmation logic for harder cases like irregular cycles, and Clue adds back history, so the ring can keep collecting temperature and recovery signals in the background while Ultrahuman layers on fertility, pregnancy, and postpartum use cases.

  • Natural Cycles still centers the app workflow. Even when paired with Oura, users sync the ring, view fertility status in the app, and regularly log temperature related data and other cycle inputs there. Ultrahuman is aiming to collapse more of that workflow into passive sensing from the ring itself.
  • Maven is similar in lifecycle coverage, not product form. Its business is virtual care and employer benefits across fertility, maternity, postpartum, and menopause, with providers and care coordination as the core product. Ultrahuman is approaching the same stages through continuous biomarker tracking, not clinician led navigation.
  • There is a proven template here. Oura used temperature sensing plus a Natural Cycles partnership to extend a sleep ring into fertility, and later expanded women’s health further. Ultrahuman is following that playbook with more owned condition logic through acquisition, while doing it at a smaller scale, about $140M latest estimated revenue versus Oura at $1B in 2025.

This points toward smart rings becoming an always on health data layer for condition specific services. As Ultrahuman adds more specialized modules, the opportunity is to move from selling a device to selling recurring, high value health programs on top of an installed ring base, especially in categories where daily manual logging has limited adoption.